Is there any role for alpha-blockers to treate lower urinary tract symptomatology after ureteral stenting?

Internal ureteral stents are associated with lower urinary tract symptomatology and can cause significant patient morbidity. This study aimed to evaluate the role of alpha-blockers as a treatment for stent-related symptoms. Sixty patients were scheduled for ureteral stenting after retrieval of lower ureteric stones. Thirty patients received Tamsulosin 0.4mg capsule daily postoperative and the other 30 patients did not received Tamsulosin. No significant difference was obtained between the groups with regard to age, sex, or postoperative haernaturea. Also, no statistically significant difference as regard suprapubic discomfort in the 2 groups on day 0, 1 and 6 [p 0.04], as well in urinary frequency, urgency or dysuria between the groups on the postoperative day-1. The irritative symptoms significantly reduced in both groups on day 6 [p<0.001]. Tamsulosin has no significant effect on stented patients in terms of bladder pain relief and irritative bladder symptoms